Alexander S. Streng

543 citations

14 papers · 304 indexed · h-index 10

Co-authors: Marja P. van Dieijen‐Visser Will K. W. H. Wodzig Douwe de Boer Otto Bekers Eline P.M. Cardinaels Jeroen P. Kooman Edwin C.M. Mariman Freek G. Bouwman
Topics: Acute Myocardial Infarction Research (5 papers)COVID-19 Clinical Research Studies (3 papers)Signaling Pathways in Disease (2 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Infectious Diseases
Journals: SHILAP Revista de lepidopterologíaBiochemical and Biophysical Research Communications Clinical Chemistry
Partner nations: Netherlands Japan United States

In The Last Decade

Alexander S. Streng

13 papers receiving 297 citations

Peers

Countries citing papers authored by Alexander S. Streng

Since Specialization

Citations

This map shows the geographic impact of Alexander S. Streng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander S. Streng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander S. Streng more than expected).

Fields of papers citing papers by Alexander S. Streng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander S. Streng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander S. Streng. The network helps show where Alexander S. Streng may publish in the future.

Co-authorship network of co-authors of Alexander S. Streng

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander S. Streng. A scholar is included among the top collaborators of Alexander S. Streng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander S. Streng. Alexander S. Streng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping 2024 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),(unknown),Alexander S. Streng,Maarten A.C. Broeren,Maarten J. Deenen,Joost L. J. van Dongen,Luc Brunsveld,Volkher Scharnhorst,Daan van de Kerkhof	0
2	Quantification of uracil, dihydrouracil, thymine and dihydrothymine for reliable dihydropyrimidine dehydrogenase (DPD) phenotyping critically depend on blood and plasma storage conditions 2022 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),Alexander S. Streng,(unknown),Maarten A.C. Broeren,Maarten J. Deenen,Joost L. J. van Dongen,(unknown),(unknown),Luc Brunsveld,Volkher Scharnhorst,Daan van de Kerkhof	10
3	Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort 2021 ·Thrombosis Journal ·Mark M. G. Mulder,(unknown),(unknown),(unknown),Alexander S. Streng,Renske H. Olie,Hester A. Gietema,Henri M.H. Spronk,Iwan C.C. van der Horst,Jan-Willem E. M. Sels,Joachim E. Wildberger,Sander M. J. van Kuijk,Ronny M. Schnabel,Hugo Ten Cate,Yvonne Henskens,Bas C. T. van Bussel	13
4	Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation 2021 ·Frontiers in Cardiovascular Medicine ·(unknown),(unknown),Mark M. G. Mulder,(unknown),Jan-Willem E. M. Sels,Renske H. Olie,Bart Spaetgens,Alexander S. Streng,Paul Verhezen,Iwan C.C. van der Horst,Hugo Ten Cate,Henri M.H. Spronk,Bas C. T. van Bussel,Yvonne Henskens	36
5	Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO 2020 ·SHILAP Revista de lepidopterología ·Alexander S. Streng,Thijs Delnoij,Mark M. G. Mulder,Jan Willem Sels,Rick J. H. Wetzels,Paul Verhezen,Renske H. Olie,Jeroen P. Kooman,Sander M. J. van Kuijk,Lloyd Brandts,Hugo Ten Cate,Roberto Lorusso,Iwan C.C. van der Horst,Bas C. T. van Bussel,Yvonne Henskens	29
6	Mass Spectrometric Identification of Cardiac Troponin T in Urine of Patients Suffering from Acute Myocardial Infarction 2018 ·The Journal of Applied Laboratory Medicine ·Alexander S. Streng,Noreen van der Linden,(unknown),Otto Bekers,Freek G. Bouwman,Edwin C.M. Mariman,Steven J.R. Meex,Will K. W. H. Wodzig,Douwe de Boer	7
7	Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction 2017 ·Clinical Chemistry ·Alma M.A. Mingels,Eline P.M. Cardinaels,Natascha J.H. Broers,(unknown),Alexander S. Streng,Marja P. van Dieijen‐Visser,Jeroen P. Kooman,Otto Bekers	53
8	Cardiac troponin T degradation in serum is catalysed by human thrombin 2016 ·Biochemical and Biophysical Research Communications ·Alexander S. Streng,Douwe de Boer,William P. T. M. van Doorn,(unknown),Otto Bekers,Will K. W. H. Wodzig	22
9	Development of a targeted selected ion monitoring assay for the elucidation of protease induced structural changes in cardiac troponin T 2016 ·Journal of Proteomics ·Alexander S. Streng,Douwe de Boer,Freek G. Bouwman,Edwin C.M. Mariman,Arjen Scholten,Marja P. van Dieijen‐Visser,Will K. W. H. Wodzig	25
10	Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T 2016 ·Data in Brief ·Alexander S. Streng,Douwe de Boer,Freek G. Bouwman,Edwin C.M. Mariman,Arjen Scholten,Marja P. van Dieijen‐Visser,Will K. W. H. Wodzig	4
11	Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction 2016 ·Clinical Chemistry ·Alexander S. Streng,Douwe de Boer,William P. T. M. van Doorn,Freek G. Bouwman,Edwin C.M. Mariman,Otto Bekers,Marja P. van Dieijen‐Visser,Will K. W. H. Wodzig	36
12	Cardiac troponin in ischemic cardiomyocytes: Intracellular decrease before onset of cell death 2014 ·Experimental and Molecular Pathology ·Alexander S. Streng,Leo Jacobs,Robert W. Schwenk,Eline P.M. Cardinaels,Steven J.R. Meex,Jan F. C. Glatz,Will K. W. H. Wodzig,Marja P. van Dieijen‐Visser	29
13	Hierarchical management of a heterarchical manufacturing grid 2014 ·(unknown),(unknown),(unknown),Alexander S. Streng,(unknown),(unknown),(unknown),(unknown),John‐Jules Ch. Meyer	2
14	Posttranslational modifications of cardiac troponin T: An overview 2013 ·Journal of Molecular and Cellular Cardiology ·Alexander S. Streng,Douwe de Boer,Jolanda van der Velden,Marja P. van Dieijen‐Visser,Will K. W. H. Wodzig	38

About Alexander S. Streng

Alexander S. Streng is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Infectious Diseases, having authored 14 papers that have together received 304 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Internal Medicine (31 citations), Cardiology and Cardiovascular Medicine (176 citations) and Infectious Diseases (53 citations). Alexander S. Streng has collaborated with scholars based in Netherlands, Japan and United States. Frequent co-authors include Marja P. van Dieijen‐Visser, Will K. W. H. Wodzig, Douwe de Boer, Otto Bekers, Eline P.M. Cardinaels, Jeroen P. Kooman, Edwin C.M. Mariman, Freek G. Bouwman, Jolanda van der Velden and William P. T. M. van Doorn. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact